Skip to main content
. 2014 Jul 10;14:504. doi: 10.1186/1471-2407-14-504

Table 5.

Survival of patients according to first line chemotherapy

 
Median overall survival
  Time in months (95% CI)
Cisplatin + taxanes (N = 46)
14.2 (10.8-19.6)
Carboplatin + taxanes (N = 69)
10.5 (7.6-13.1)
Platinum without taxanes (N = 28)
11.2 (8.6-25.3)
Other chemotherapy (N = 48)
5.6 (4.3-8.1)
Clinical trials testing not approved regimens (N = 7) 5.7 (1.7 – NR)

NR = Non Reached.